Birmingham Hospital Opens New Automated Blood Sciences Laboratory
|
By LabMedica International staff writers Posted on 14 Jun 2012 |

Image: The new Queen Elizabeth Hospital Birmingham’s laboratory uses state-of-the-art Roche analytical platforms to reduce turnaround times (Photo courtesy of the University Hospitals Birmingham NHS Foundation Trust).
A new automated blood sciences laboratory in a Birmingham hospital has an automated track system that simplifies laboratory processes and improves turnaround times.
The University Hospitals Birmingham NHS Foundation Trust has opened an automated blood sciences laboratory at the new Queen Elizabeth Hospital in Birmingham (Birmingham, United Kingdom). Equipped with state-of-the-art Roche (Burgess Hill, United Kingdom) analytical platforms and track system, the new laboratory ensures a very efficient workflow and will reduce turnaround times (TAT) for routine, high throughput work.
The track system consists of two cobas 8000 platforms (one with two cobas c 701 chemistry modules and two cobas e 602 immunoassay modules and the other with one cobas c 701 and two cobas e 602 modules), a modular preanalytics module and a cobas p 501/701 post-analytical unit for automated sample storage and retrieval.
The cobas 8000 modular analyzer series is designed for high workload laboratories and can cover a range of 3 up to 15 million tests per year. With a peak throughput of 8,400 tests per hour and many innovative design elements to allow unrestricted sample flow and intelligent sample routing, the cobas 8000 modular analyzer series significantly improves sample turnaround time and efficiently addresses peak demands. High speed, intelligent sample dynamics, and workflow improvements further enhance productivity and efficiency for high workload laboratories.
“The fully automated track system with pre- and post-analytics has eliminated the need for manual transfer and storage of samples once they are loaded on the system”, explained laboratory manager, Chris Gaskin. “The cobas 8000 platforms are designed for high throughput and the whole Roche solution has helped us to be more lean in our processes and is much more TAT efficient for our high workloads.”
The laboratory also has a standalone cobas p 512 module for automated sample receipt. “In the next few months, we aim to introduce a pneumatic sample delivery system and ward order communications throughout the hospital,” Chris Gaskin concluded. “When a test is requested on the ward, a barcode label will be printed automatically. Then, when samples arrive in the laboratory, they will be loaded directly onto the cobas p 512. The system will register receipt on Laboratory Information Management System (LIMS) and then sort the samples into appropriate racks, depending on their destination. This will eliminate the need for paperwork, allowing the process to be entirely electronic from request to result for the very first time. It will streamline sample reception significantly and will further reduce turnaround times.”
Related Links:
Queen Elizabeth Hospital in Birmingham
Roche
The University Hospitals Birmingham NHS Foundation Trust has opened an automated blood sciences laboratory at the new Queen Elizabeth Hospital in Birmingham (Birmingham, United Kingdom). Equipped with state-of-the-art Roche (Burgess Hill, United Kingdom) analytical platforms and track system, the new laboratory ensures a very efficient workflow and will reduce turnaround times (TAT) for routine, high throughput work.
The track system consists of two cobas 8000 platforms (one with two cobas c 701 chemistry modules and two cobas e 602 immunoassay modules and the other with one cobas c 701 and two cobas e 602 modules), a modular preanalytics module and a cobas p 501/701 post-analytical unit for automated sample storage and retrieval.
The cobas 8000 modular analyzer series is designed for high workload laboratories and can cover a range of 3 up to 15 million tests per year. With a peak throughput of 8,400 tests per hour and many innovative design elements to allow unrestricted sample flow and intelligent sample routing, the cobas 8000 modular analyzer series significantly improves sample turnaround time and efficiently addresses peak demands. High speed, intelligent sample dynamics, and workflow improvements further enhance productivity and efficiency for high workload laboratories.
“The fully automated track system with pre- and post-analytics has eliminated the need for manual transfer and storage of samples once they are loaded on the system”, explained laboratory manager, Chris Gaskin. “The cobas 8000 platforms are designed for high throughput and the whole Roche solution has helped us to be more lean in our processes and is much more TAT efficient for our high workloads.”
The laboratory also has a standalone cobas p 512 module for automated sample receipt. “In the next few months, we aim to introduce a pneumatic sample delivery system and ward order communications throughout the hospital,” Chris Gaskin concluded. “When a test is requested on the ward, a barcode label will be printed automatically. Then, when samples arrive in the laboratory, they will be loaded directly onto the cobas p 512. The system will register receipt on Laboratory Information Management System (LIMS) and then sort the samples into appropriate racks, depending on their destination. This will eliminate the need for paperwork, allowing the process to be entirely electronic from request to result for the very first time. It will streamline sample reception significantly and will further reduce turnaround times.”
Related Links:
Queen Elizabeth Hospital in Birmingham
Roche
Latest Hematology News
- Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
- Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
- Higher Ferritin Threshold May Improve Iron Deficiency Detection in Children
- Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
- Advanced CBC-Derived Indices Integrated into Hematology Platforms
- Blood Test Enables Early Detection of Multiple Myeloma Relapse
- Single Assay Enables Rapid HLA and ABO Genotyping for Transplant Matching
- Prognostic Biomarker Identified in Diffuse Large B-Cell Lymphoma
- Routine Blood Test Parameters Link Anemia to Cancer Risk and Mortality
- Prognostic Tool Guides Personalized Treatment in Rare Blood Cancer
- New Platelet Function Assay Enables Monitoring of Antiplatelet Therapy
- Open Multi-Omics Platform Identifies Prognostic Subtypes in Blood Cancers
- AI-Powered Digital Workflow Standardizes Bone Marrow Aspirate Morphology
- Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
- New Guidelines Aim to Improve AL Amyloidosis Diagnosis
- Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
Channels
Clinical Chemistry
view channel
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read moreMolecular Diagnostics
view channel
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read more
Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead
Lung cancer remains a leading cause of cancer death, and many cases are detected only after symptoms appear. Current screening programs largely target people with a history of smoking, leaving other at-risk... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read morePathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more








